Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
No Longer Available NCT05274204

Individual Patient Expanded Access to CA102N

Conditions: Advanced or Metastatic Colorectal Cancer (mCRC)

Sponsor: Holy Stone Healthcare Co., Ltd

Summary

This study is an individual patient expanded access protocol that the subject enrolled had completed the combination treatment of CA102N plus Lonsurf for at least 12 cycles.

Eligibility Criteria

Inclusion Criteria: \- Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05274204). StuddyBuddy aggregates publicly available trial information.